Recapture and retreatment rates with ixekizumab after withdrawal of therapy in patients with axial spondyloarthritis: results at week 104 from a randomised placebo-controlled withdrawal study.

Autor: Landewé, Robert B. M., Poddubnyy, Denis, Rahman, Proton, Van den Bosch, Filip E., Bolce, Rebecca, Leage, Soyi Liu, Lisse, Jeffrey R., So Young Park, Gensler, Lianne
Zdroj: Annals of the Rheumatic Diseases; Feb2023, Vol. 82 Issue 2, following p212-216, 17p
Databáze: Complementary Index